ZA977239B - Novel thrombin inhibitors - Google Patents

Novel thrombin inhibitors

Info

Publication number
ZA977239B
ZA977239B ZA977239A ZA977239A ZA977239B ZA 977239 B ZA977239 B ZA 977239B ZA 977239 A ZA977239 A ZA 977239A ZA 977239 A ZA977239 A ZA 977239A ZA 977239 B ZA977239 B ZA 977239B
Authority
ZA
South Africa
Prior art keywords
thrombin inhibitors
novel thrombin
novel
inhibitors
thrombin
Prior art date
Application number
ZA977239A
Other languages
English (en)
Inventor
Dorit Baucke
Udo Lange
Helmut Mack
Werner Seitz
Thomas Zierke
Hans Wolfgang Hoeffken
Wilfried Hornberger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA977239B publication Critical patent/ZA977239B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA977239A 1996-08-14 1997-08-13 Novel thrombin inhibitors ZA977239B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19632773A DE19632773A1 (de) 1996-08-14 1996-08-14 Neue Thrombininhibitoren

Publications (1)

Publication Number Publication Date
ZA977239B true ZA977239B (en) 1999-02-15

Family

ID=7802624

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA977239A ZA977239B (en) 1996-08-14 1997-08-13 Novel thrombin inhibitors

Country Status (30)

Country Link
US (1) US6114358A (sk)
EP (1) EP0956294B1 (sk)
JP (1) JP4089981B2 (sk)
KR (1) KR20000030002A (sk)
CN (1) CN1228783A (sk)
AR (1) AR009070A1 (sk)
AT (1) ATE268781T1 (sk)
AU (1) AU735364B2 (sk)
BG (1) BG103096A (sk)
BR (1) BR9711191A (sk)
CA (1) CA2263220A1 (sk)
CO (1) CO4900030A1 (sk)
CZ (1) CZ299634B6 (sk)
DE (2) DE19632773A1 (sk)
DK (1) DK0956294T3 (sk)
ES (1) ES2221062T3 (sk)
HR (1) HRP970441B1 (sk)
HU (1) HUP0001826A3 (sk)
ID (1) ID17873A (sk)
IL (1) IL127751A0 (sk)
MY (1) MY132820A (sk)
NO (1) NO990662L (sk)
NZ (1) NZ333679A (sk)
PL (1) PL188411B1 (sk)
PT (1) PT956294E (sk)
RU (1) RU2175328C2 (sk)
SK (1) SK284915B6 (sk)
TR (1) TR199900310T2 (sk)
WO (1) WO1998006741A1 (sk)
ZA (1) ZA977239B (sk)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
CA2317761A1 (en) * 1998-01-26 1999-07-29 Basf Aktiengesellschaft Thrombin inhibitors
WO1999037611A1 (de) * 1998-01-26 1999-07-29 Basf Aktiengesellschaft Heterocyclische amidine als kallikrein protease inhibitoren
NZ506507A (en) * 1998-02-09 2003-08-29 Dimensional Pharm Inc Heteroaryl amidine, methylamidine or guanidine derivatives useful as urokinase inhibitors
BR9917036A (pt) * 1999-02-09 2002-07-30 Dimensional Pharm Inc Amidinas heteroarila, metilamidinas e guanidinas como inibidores de protease
TR200102912T2 (tr) 1999-04-09 2002-03-21 Basf Ag. Trombin ihtibit”rlerinin ”n ila‡larì.
JP2002541252A (ja) * 1999-04-09 2002-12-03 ビーエーエスエフ アクチェンゲゼルシャフト アミジンの製造
WO2000061608A2 (de) * 1999-04-09 2000-10-19 Basf Aktiengesellschaft Niedermolekulare inhibitoren von komplementproteasen
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
KR20010002891A (ko) * 1999-06-18 2001-01-15 성재갑 아릴 또는 헤테로아릴 그룹을 갖는 트롬빈 억제제 및 그 제조 방법
DE19933861A1 (de) * 1999-07-23 2001-01-25 Basf Ag Verfahren zur Herstellung von 2-Aminomethyl-4-cyano-thiazol
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
FI122575B (fi) 2006-12-04 2012-03-30 Dieffenbacher Panelboard Oy Laitteisto kuitujen, kuten lastujen sirottelemiseksi
CA2829790C (en) 2010-03-30 2018-06-05 Verseon Corporation Multisubstituted aromatic compounds as inhibitors of thrombin
KR20150130405A (ko) 2013-03-15 2015-11-23 베르선 코포레이션 트롬빈의 억제제로서의 할로게노피라졸
PT2968297T (pt) * 2013-03-15 2019-01-10 Verseon Corp Compostos aromáticos multissubstituídos como inibidores da serina protease
CN103520160B (zh) * 2013-10-17 2015-04-22 广东药学院 三棱中肽类化合物的应用
WO2016044662A1 (en) 2014-09-17 2016-03-24 Verseon Corporation Pyrazolyl-substituted pyridone compounds as serine protease inhibitors
ES2931460T3 (es) 2015-02-27 2022-12-29 Verseon Int Corporation Compuestos de pirazol sustituido como inhibidores de serina proteasa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
NZ302649A (en) * 1995-02-17 2000-01-28 Basf Ag Dipeptide amidine derivatives, preparation and pharmaceutical compositions thereof
DE19632772A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) * 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren

Also Published As

Publication number Publication date
AU3941797A (en) 1998-03-06
IL127751A0 (en) 1999-10-28
HRP970441A2 (en) 1998-06-30
NZ333679A (en) 1999-09-29
CZ299634B6 (cs) 2008-10-01
JP4089981B2 (ja) 2008-05-28
WO1998006741A1 (de) 1998-02-19
HRP970441B1 (en) 2005-04-30
JP2000516598A (ja) 2000-12-12
MY132820A (en) 2007-10-31
DK0956294T3 (da) 2004-10-11
ATE268781T1 (de) 2004-06-15
RU2175328C2 (ru) 2001-10-27
CO4900030A1 (es) 2000-03-27
ES2221062T3 (es) 2004-12-16
PT956294E (pt) 2004-10-29
NO990662D0 (no) 1999-02-12
PL188411B1 (pl) 2005-01-31
SK284915B6 (sk) 2006-02-02
CA2263220A1 (en) 1998-02-19
CZ48699A3 (cs) 1999-05-12
DE59711714D1 (de) 2004-07-15
US6114358A (en) 2000-09-05
BG103096A (en) 1999-09-30
EP0956294A1 (de) 1999-11-17
HUP0001826A3 (en) 2002-01-28
SK899A3 (en) 1999-06-11
PL331540A1 (en) 1999-07-19
EP0956294B1 (de) 2004-06-09
KR20000030002A (ko) 2000-05-25
TR199900310T2 (xx) 1999-04-21
ID17873A (id) 1998-02-05
AU735364B2 (en) 2001-07-05
NO990662L (no) 1999-02-12
BR9711191A (pt) 1999-08-17
CN1228783A (zh) 1999-09-15
DE19632773A1 (de) 1998-02-19
AR009070A1 (es) 2000-03-08
HUP0001826A2 (hu) 2000-09-28

Similar Documents

Publication Publication Date Title
EP0927035A4 (en) THROMBIN INHIBITORS
EP0969840A4 (en) THROMBIN INHIBITORS
EP0820453A4 (en) THROMBIN INHIBITORS
HRP960075B1 (en) New thrombin inhibitors
EP0923372A4 (en) PYRIDINONE THROMBINE INHIBITORS
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
ZA977239B (en) Novel thrombin inhibitors
AU3832895A (en) Thrombin inhibitors
EP1124822A4 (en) THROMBIN INHIBITORS
EP0971891A4 (en) THROMBIN INHIBITORS
PL328307A1 (en) Serinic protease inhibitors
PL328875A1 (en) Serinic protease inhibitors
PL331803A1 (en) Bidonoric metaloprotease inhibitors
PL328223A1 (en) Aspartil protease inhibitors
IL136139A0 (en) Thrombin inhibitors
AU3396697A (en) Thrombin inhibitor
IL117437A0 (en) Novel thrombin inhibitors
GB9613718D0 (en) Thrombin inhibitors
IL121474A0 (en) Thrombin inhibitors
AU2908197A (en) Thrombin inhibitors
EP1017383A4 (en) THROMBIN INHIBITORS
EP1039907A4 (en) THROMBIN INHIBITORS
EP1027333A4 (en) THROMBIN INHIBITORS
GB9624278D0 (en) Thrombin inhibitors
GB9624319D0 (en) Thrombin inhibitors